Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast



Status:Completed
Conditions:Cancer, Kidney Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:21 - 99
Updated:4/21/2016
Start Date:March 2008
End Date:November 2011

Use our guide to learn which trials are right for you!

Evaluation of Renal Masses Using Ultrasound Intravenous Microbubble Contrast

The purpose of this study is to evaluate the blood flow in kidney masses by using ultrasound
microbubble contrast material, and to see if results from ultrasound contrast studies can
predict if a kidney mass is benign or malignant. Patterns of blood flow in the kidney mass
will be examined to see if:

1. benign kidney masses can be distinguished from kidney cancers and

2. if slow growing, lower risk cancers have different blood flow compared to clear cell
cancer which is the most common type of kidney cancer.


Inclusion Criteria:

- Any adult patient who is planned or scheduled for surgical excision or biopsy of a
solid or complex cystic renal mass would be eligible for the study

- Histology of the renal mass must be unknown at the time of enrollment

- Patients who have renal masses that are evident on conventional US imaging

- Patients will have a correlative abdominal CT and/or MRI

Exclusion Criteria:

- Patients with any history of cardiac shunts.

- Patients with history of pulmonary hypertension or unstable cardiopulmonary
conditions, including patients on mechanical ventilation.

- Patients without peripheral IV access

- Pregnant patients and children

- Patients with any known contrast allergies, allergy to perflutren, or any components
of Definity or microbubble contrast

- Patients who have renal masses that are not evident on conventional US imaging
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials